by
According to the Foreclaro Global Research, the
Global
Immunohistochemistry Market size was valued at USD 2487.4 million in 2024. The report “Global
Immunohistochemistry Market Segmentation By Product Type
(Antibodies {Primary Antibodies, Secondary Antibodies}, Reagents, Equipment
{Slide Staining Systems, Tissue Microarrayers, Slide Scanners}, Kits), By
Application (Diagnostics {Cancer, Infectious Diseases, Autoimmune Diseases,
Neurodegenerative Diseases}, Drug Development, Research), By Technology
(Chromogenic IHC, Fluorescent IHC, In Situ Hybridization (ISH), Digital
Pathology & AI-Based IHC), By End-User (Hospitals & Diagnostic Labs,
Pharmaceutical & Biotech Companies, Academic & Research Institutes,
Contract Research Organizations (CROs))- Industry Trends and Forecast to 2033” gives a detailed insight into
current market dynamics and provides analysis on future market growth.
Immunohistochemistry (IHC) is an effective
laboratory approach that detects precise antigens in tissue sections via an
appropriate binding of antibodies, visualized the usage of chromogenic dyes or
fluorescent markers. Widely utilized in pathology, IHC allows for the detection
of disease-associated proteins, allowing correct most cancers, subtyping, and
evaluation of predictive and prognostic biomarkers vital for focused therapies.
Beyond oncology, it plays a vital role in reading infectious, autoimmune, and
neurodegenerative sicknesses via way of means of highlighting cell
modifications within tissue architecture. Advances in multiplex staining,
computerized slide scanners, and virtual pathology have advanced accuracy,
consistency, and efficiency, making IHC in high demand in each scientific and study
setting. The approach's integration with synthetic intelligence, in addition,
complements records interpretation and workflow automation. Supported via way
of means of main diagnostics and existence sciences companies, IHC keeps to
evolve, gambling a principal position in personalized medicine, drug
development, and translational studies via way of means of bridging molecular
biology with visible histological evaluation to manual specific clinical
decisions.
Have any questions or need more information?
Click the link below to request a sample or make an inquiry before making your
purchase:
https://foreclaroglobalresearch.com/research-report/global-immunohistochemistry-market
Global Immunohistochemistry
Market Report Highlights
· Surging
demand in oncology diagnostics because of a growing prevalence of cancers and
the developing want for biomarker-pushed remedy planning.
· Technological
advancements, along with multiplex IHC, virtual pathology platforms,
computerized staining systems, and AI-assisted picture analysis, which might be
improving diagnostic accuracy and laboratory workflow efficiency.
· Expansion
of partner diagnostics, especially in immuno-oncology, strengthening the
position of IHC in personalized remedy selection.
· Growing
adoption in studies and drug development, wherein IHC performs a important
position in biomarker discovery, pharmacodynamic studies, and translational
studies.
· Geographic
boom variations, with North America and Europe being main in technological
utilization, and Asia-Pacific rising unexpectedly because of growing healthcare
infrastructure investments and growing disease awareness.
· Challenges
in standardization and cost, along with variability in staining interpretation,
the need for professional pathologists, and excessive expenses related to
superior reagents and equipment, though those are balanced via way of means of
increasing get entry to and funding in rising markets.
Foreclaro
Global Research has segmented the Immunohistochemistry Market report based on Product
Type, Application, Technology, End User, and region:
Immunohistochemistry Market, Product Type
Outlook (Revenue - USD Million, 2020 - 2033)
Antibodies
·
Primary
Antibodies
·
Secondary
Antibodies
Reagents
Equipment
·
Slide
Staining Systems
·
Tissue
Microarrayers
·
Slide
Scanners
Kits
Immunohistochemistry Market, Application
Outlook (Revenue - USD Million, 2020 - 2033)
Diagnostics
·
Cancer
·
Infectious
Diseases
·
Autoimmune
Diseases
·
Neurodegenerative
Diseases
Drug Development
Research
Immunohistochemistry Market, Technology
Outlook (Revenue - USD Million, 2020 - 2033)
Chromogenic IHC
Fluorescent IHC
In Situ Hybridization (ISH)
Digital Pathology & AI-Based IHC
Immunohistochemistry Market, End
User Outlook (Revenue - USD Million, 2020 - 2033)
Hospitals & Diagnostic Labs
Pharmaceutical & Biotech Companies
Academic & Research Institutes
Contract Research Organizations (CROs)
Immunohistochemistry Market,
Regional Outlook (Revenue - USD Million, 2020 - 2033)
North
America
·
United
States
·
Canada
·
Mexico
Europe
·
United
Kingdom
·
Germany
·
France
·
Spain
·
Italy
·
Rest
of Europe
Asia
Pacific
·
China
·
India
·
Japan
·
Australia
·
South
Korea
·
Rest
of Asia Pacific
Latin
America
·
Brazil
·
Argentina
·
Rest
of Latin America
Middle East
& Africa
·
Saudi
Arabia
·
South
Africa
·
Rest
of MEA
Global Immunohistochemistry Market Key Players
·
Thermo Fisher Scientific Inc.
·
F. Hoffmann-La Roche Ltd.
·
Merck KGaA
·
Danaher Corporation
·
PerkinElmer Inc.
·
Bio-Rad Laboratories, Inc.
·
Cell Signaling Technology, Inc.
·
Bio SB
·
Agilent Technologies, Inc.
·
Abcam Limited.
